Stefanie Schreiber

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

Walter Reinisch, William J. Sandborn, Daniël W. Hommes et al. · Gut · 2011 · 887 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study

Andreas Charidimou, Grégoire Boulouis, Matthew P. Frosch et al. · The Lancet Neurology · 2022 · 659 citations · Full text

Medicine, Neurology, Neuroscience +11

Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease

Stefanie Schreiber, Walter Reinisch, J F Colombel et al. · Journal of Crohn s and Colitis · 2012 · 189 citations

Medicine, Clinical Sciences, Pharmacotherapy +16

Blood brain barrier breakdown as the starting point of cerebral small vessel disease? - New insights from a rat model

Stefanie Schreiber, Celine Zoe Bueche, Cornelia Garz et al. · Experimental & Translational Stroke Medicine · 2013 · 145 citations · Full text

Medicine, Neurology, Neuroscience +17

Hippocampal vascular reserve associated with cognitive performance and hippocampal volume

Valentina Perosa, Anastasia Priester, Gabriel Ziegler et al. · Brain · 2019 · 145 citations · Full text

Life Sciences, Neurology, Neuroscience +16